Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen patch for knee osteoarthritis
CTR20252551Phase 3Completed
- Sponsor
- Beijing Fuyuan Pharmaceutical
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketoprofen in knee osteoarthritis (OA) (3 arms), sponsored by Beijing Fuyuan Pharmaceutical. Primary endpoint: Change from baseline in VAS pain score during walking at week 2. Started Jul 2025; status: completed.
02
Drugs
ketoprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20252551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252551.